Article
PAPER OF THE WEEK: Predictions About Clinical Pathways
Author(s):
With our current issue of Evidence-Based Oncology™ focusing on clinical pathways in cancer care, we look back at one of our most-read papers of 2016.
Welcome to Paper of the Week, which looks back at research and commentary from the past 25 years in The American Journal of Managed Care®, and why they matter today.
With our current issue of Evidence-Based Oncology™ focusing on clinical pathways in cancer care, we look back at one of our most-read papers of 2016.
“Care Pathways in US Healthcare Settings: Current Successes and Limitations and Future Challenges” predicted that pathways would continue to take hold as a way to improve healthcare quality and patient outcomes.
Funded by the National Pharmaceutical Council, the paper called for key elements in pathways:
- Increased use of pathways with specialty drugs in episodes of care
- Transparency in development, implementation, and evaluation
- More research on the effect of pathways
For the full paper, visit ajmc.com.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
